Suppr超能文献

保皮乳房切除术和即刻乳房重建在局部复发性乳腺癌治疗中的应用。

Skin-sparing mastectomy and immediate breast reconstruction in the management of locally recurrent breast cancer.

机构信息

Department of Plastic Surgery and Breast Surgery Unit, Helsinki University Central Hospital, Helsinki, Finland.

出版信息

Ann Surg Oncol. 2010 Jun;17(6):1669-74. doi: 10.1245/s10434-010-0957-8. Epub 2010 Feb 12.

Abstract

AIM

To investigate whether skin-sparing mastectomy (SSM) and immediate breast reconstruction (IBR) is a possible treatment option in selected cases of locally recurrent breast cancer after previous breast-conserving therapy (BCT).

MATERIAL AND METHODS

Sixty consecutive patients were treated by SSM and IBR between 1995 and 2008 for ipsilateral breast tumour recurrence (IBTR). Selection criteria consisted of: IBTR <3 cm size, not infiltrating skin or chest wall, primarily node negative, recurrence >3 years after primary operation, and no metastases. Patient records were analysed retrospectively and follow-up data on patient outcome included.

RESULTS

The reconstruction method consisted of 40 free abdominal flaps, 18 latissimus dorsi (LD) flaps with or without an implant, and two cases of implant only. Twenty-three patients received adjuvant oncological therapy. During median follow-up of 66 months, 11 patients (18%) developed disease relapse, including 6 (10%) local re-recurrences.

CONCLUSION

IBR is a possible treatment option for patients who develop local recurrence following earlier BCT. Our local re-recurrence rate of 10% compares well with that following salvage mastectomy for IBTR. Of patients, 43% did not actually meet our selection criteria but yet appeared to fare well in terms of outcome. Therefore we should re-evaluate our selection criteria.

摘要

目的

探讨在既往保乳治疗(BCT)后局部复发的乳腺癌患者中,对于特定病例,皮肤保留乳房切除术(SSM)和即刻乳房重建(IBR)是否为一种可行的治疗选择。

材料与方法

1995 年至 2008 年间,我们对 60 例同侧乳房肿瘤复发(IBTR)患者行 SSM 和 IBR 治疗。选择标准包括:IBTR 直径<3cm,未浸润皮肤或胸壁,最初淋巴结阴性,复发距原发手术>3 年,且无远处转移。对患者的病历进行回顾性分析,并对患者结局的随访数据进行分析。

结果

重建方法包括 40 例游离腹部皮瓣、18 例背阔肌(LD)皮瓣联合或不联合植入物,以及 2 例仅植入物。23 例患者接受了辅助肿瘤学治疗。中位随访 66 个月期间,11 例患者(18%)出现疾病复发,包括 6 例(10%)局部再复发。

结论

对于早期 BCT 后发生局部复发的患者,IBR 是一种可行的治疗选择。我们的局部再复发率为 10%,与 IBTR 行挽救性乳房切除术的结果相当。我们的 43%的患者实际上不符合我们的选择标准,但在结局方面似乎表现良好。因此,我们应重新评估我们的选择标准。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验